Real-world toxicity and effectiveness of ixazomib, lenalidomide, and dexamethasone in Korean patients with relapsed and/or refractory multiple myeloma. - Lee JH; Kim SH; Kim HR; Min CK; Lee JJ; Shin HJ; Jo JC; Lee JY; Moon JH; Kim K (International journal of hematology, 2023)